Insider trades
Cyrus Harmon, Director of Olema Pharmaceuticals OLMA, has filed 0 purchases and 39 sales on the open market. Over the past 12 months that comes to a net sale of $452.6K. The latest trade was on 06/18.
Cyrus Harmon
Director
- Company
- Olema Pharmaceuticals OLMA
- First filing
- 23/02/02
- Trades
- 45 trades
- Buys / sales
- 0 / 39
- 12-month net buying
- −$452.6K
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/20 | 01/21 | 10,000 sh | $26.88 | $268,800 | −1.4% | |
| Open-market sale | 01/14 | 01/16 | 3,489 sh | $29.12 | $101,599.68 | −0.5% | |
| Open-market sale | 25/12/22 | 25/12/29 | 2,881 sh | $28.53 | $82,194.93 | −0.4% | |
| Open-market sale | 25/09/16–25/09/18 | 25/09/18 | 25,000 sh4 trades | $8.19avg. | $204,840.64 | No record | |
| Open-market sale | 24/12/10–24/12/11 | 24/12/11 | 16,393 sh3 trades | $9.03avg. | $147,955.81 | −2.1% | |
| Open-market sale10b5-1 plan | 24/07/29–24/07/30 | 24/07/31 | 5,000 sh2 trades | $15.57avg. | $77,871.98 | −0.7% | |
| Open-market sale10b5-1 plan | 24/07/11 | 24/07/12 | 5,000 sh | $12.26 | $61,300 | −0.7% | |
| Open-market sale10b5-1 plan | 24/06/28 | 24/07/02 | 20,000 sh | $10.77 | $215,400 | −2.6% | |
| Open-market sale10b5-1 plan | 24/05/31–24/06/04 | 24/06/04 | 25,000 sh3 trades | $10.30avg. | $257,450 | −3.1% | |
| Open-market sale10b5-1 plan | 24/05/06 | 24/05/07 | 5,000 sh | $10.92 | $54,600 | −0.6% | |
| Open-market sale10b5-1 plan | 24/04/30 | 24/05/02 | 15,000 sh | $9.51 | $142,650 | −1.8% | |
| Open-market sale10b5-1 plan | 24/03/28 | 24/03/29 | 20,000 sh | $10.97 | $219,400 | −2.4% | |
| Open-market sale10b5-1 plan | 24/02/29 | 24/03/04 | 25,000 sh2 trades | $12.41avg. | $310,309 | −2.9% | |
| Open-market sale10b5-1 plan | 24/01/31–24/02/01 | 24/02/02 | 30,000 sh2 trades | $12.79avg. | $383,550 | −3.3% | |
| Open-market sale | 23/12/29 | 24/01/02 | 25,000 sh2 trades | $13.38avg. | $334,500 | −2.7% | |
| Open-market sale10b5-1 plan | 23/11/30 | 23/12/01 | 25,000 sh | $12.57 | $314,250 | −2.6% | |
| Open-market sale | 23/11/21–23/11/22 | 23/11/22 | 8,181 sh2 trades | $14.39avg. | $117,740.22 | −0.9% | |
| Open-market sale10b5-1 plan | 23/10/31–23/11/02 | 23/11/02 | 30,000 sh2 trades | $12.65avg. | $379,450 | −3.1% | |
| Open-market sale10b5-1 plan | 23/09/29 | 23/10/03 | 25,000 sh | $12.41 | $310,250 | −2.5% | |
| Open-market sale10b5-1 plan · Amendment | 23/08/16–23/09/05 | 23/09/05 | 40,000 sh3 trades | $10.22avg. | $408,700 | −3.9% |